Cormorant Asset Management, LP - Q2 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
QUOTIENT LTD30Q3 20214.3%
ASCENDIS PHARMA A/S30Q4 20224.8%
MINERVA NEUROSCIENCES INC29Q3 20214.4%
ACCELERON PHARMA INC28Q2 20213.4%
OMEROS CORP27Q3 20216.5%
MIRATI THERAPEUTICS INC25Q4 20227.6%
BLUEPRINT MEDICINES CORP25Q3 20213.6%
APELLIS PHARMACEUTICALS INC24Q3 20238.6%
NEUROCRINE BIOSCIENCES INC24Q1 20204.6%
ROCKET PHARMACEUTICALS, INC23Q3 20232.4%

View Cormorant Asset Management, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Cormorant Asset Management, LP Q2 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Ambrx Biopharma Inc.March 13, 202342,771,365-
Altimmune, Inc.February 14, 20232,600,000-
Arcellx, Inc.February 14, 20232,075,000-
BioAtla, Inc.February 14, 20232,499,250-
Eledon Pharmaceuticals, Inc.February 14, 20231,391,663-
GreenLight Biosciences Holdings, PBCFebruary 14, 20234,751,020-
Prometheus Biosciences, Inc.February 14, 2023700,000-
Tango Therapeutics, Inc.February 14, 20231,000,000-
VectivBio Holding AGFebruary 14, 20231,515,087-
Viridian Therapeutics, Inc.\DEFebruary 14, 20231,100,000-

View Cormorant Asset Management, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-29
42024-04-22
SC 13G/A2024-04-15
42024-04-03
SC 13G2024-03-21
42024-03-18
SC 13G/A2024-03-18
42024-03-11
13F-HR2024-02-14
SC 13G/A2024-02-14

View Cormorant Asset Management, LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Cormorant Asset Management, LP's holdings

CSVXLS